These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 1929228

  • 1. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.
    Hartung HP, Reiners K, Schmidt B, Stoll G, Toyka KV.
    Ann Neurol; 1991 Jul; 30(1):48-53. PubMed ID: 1929228
    [Abstract] [Full Text] [Related]

  • 2. Elevated serum levels of endothelial leukocyte adhesion molecules in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Oka N, Akiguchi I, Kawasaki T, Ohnishi K, Kimura J.
    Ann Neurol; 1994 May; 35(5):621-4. PubMed ID: 7513983
    [Abstract] [Full Text] [Related]

  • 3. Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome.
    Sharief MK, McLean B, Thompson EJ.
    Ann Neurol; 1993 Jun; 33(6):591-6. PubMed ID: 8498839
    [Abstract] [Full Text] [Related]

  • 4. T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors.
    Hartung HP, Hughes RA, Taylor WA, Heininger K, Reiners K, Toyka KV.
    Neurology; 1990 Feb; 40(2):215-8. PubMed ID: 2300238
    [Abstract] [Full Text] [Related]

  • 5. [Detection of interleukin-6 in serum and cerebrospinal fluid of patients with neuroimmunological diseases].
    Shimada K, Koh CS, Yanagisawa N.
    Arerugi; 1993 Aug; 42(8):934-40. PubMed ID: 8250733
    [Abstract] [Full Text] [Related]

  • 6. [A study of soluble form of L-selectin in blood of patients with neuroimmunological disorders].
    Sakai T, Inoue A, Koh CS, Yamazaki M, Yanagisawa N.
    Arerugi; 1996 Jul; 45(7):672-7. PubMed ID: 8831172
    [Abstract] [Full Text] [Related]

  • 7. Low-titer antibodies reactive with HTLV-I gag p19 in patients with chronic myeloneuropathy.
    Kawanishi T, Akiguchi I, Fujita M, Kameyama M, Hatanaka M.
    Ann Neurol; 1989 Oct; 26(4):515-22. PubMed ID: 2510585
    [Abstract] [Full Text] [Related]

  • 8. Immunization and risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA, Choudhary PP, Osborn M, Rees JH, Sanders EA.
    Muscle Nerve; 1996 Sep; 19(9):1230-1. PubMed ID: 8761286
    [No Abstract] [Full Text] [Related]

  • 9. [A study of soluble form of selectin family in the sera of patients with neuroimmunological disorders].
    Sakai T, Inoue A, Koh CS, Yamazaki M, Yanagisawa N.
    Rinsho Shinkeigaku; 1998 Mar; 38(3):197-202. PubMed ID: 9711113
    [Abstract] [Full Text] [Related]

  • 10. In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome.
    Saida T, Saida K, Lisak RP, Brown MJ, Silberberg DH, Asbury AK.
    Ann Neurol; 1982 Jan; 11(1):69-75. PubMed ID: 7059130
    [Abstract] [Full Text] [Related]

  • 11. Serum VEGF levels in POEMS syndrome and in immune-mediated neuropathies.
    Nobile-Orazio E, Terenghi F, Giannotta C, Gallia F, Nozza A.
    Neurology; 2009 Mar 17; 72(11):1024-6. PubMed ID: 19289745
    [No Abstract] [Full Text] [Related]

  • 12. Gm haplotypes in inflammatory demyelinating polyneuropathies.
    Feeney DJ, Pollard JD, McLeod JG, Stewart GJ, De Lange GG.
    Ann Neurol; 1989 Dec 17; 26(6):790-2. PubMed ID: 2557797
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Maimone D, Annunziata P, Simone IL, Livrea P, Guazzi GC.
    J Neuroimmunol; 1993 Aug 17; 47(1):55-61. PubMed ID: 8376548
    [Abstract] [Full Text] [Related]

  • 14. Anti-GD1a ganglioside antibodies in peripheral motor syndromes.
    Carpo M, Nobile-Orazio E, Meucci N, Gamba M, Barbieri S, Allaria S, Scarlato G.
    Ann Neurol; 1996 Apr 17; 39(4):539-43. PubMed ID: 8619533
    [Abstract] [Full Text] [Related]

  • 15. Search for antibodies to galactocerebroside in the serum and cerebrospinal fluid in human demyelinating disorders.
    Rostami AM, Burns JB, Eccleston PA, Manning MC, Lisak RP, Silberberg DH.
    Ann Neurol; 1987 Sep 17; 22(3):381-3. PubMed ID: 3674803
    [Abstract] [Full Text] [Related]

  • 16. In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes.
    Sawant-Mane S, Clark MB, Koski CL.
    Ann Neurol; 1991 Apr 17; 29(4):397-404. PubMed ID: 1718212
    [Abstract] [Full Text] [Related]

  • 17. Autoimmune diseases of the neuroimmune system and mental disease.
    Steiner I, Abramsky O.
    Immunol Ser; 1989 Apr 17; 45():491-511. PubMed ID: 2488144
    [No Abstract] [Full Text] [Related]

  • 18. Cold reactive antilymphocyte antibodies in neurological diseases.
    Lisak RP, Mercado F, Zweiman B.
    J Neurol Neurosurg Psychiatry; 1979 Nov 17; 42(11):1054-7. PubMed ID: 315450
    [Abstract] [Full Text] [Related]

  • 19. Demyelination induced by serum from patients with Guillain-Barré syndrome.
    Harrison BM, Hansen LA, Pollard JD, McLeod JG.
    Ann Neurol; 1984 Feb 17; 15(2):163-70. PubMed ID: 6703656
    [Abstract] [Full Text] [Related]

  • 20. Isolation and characterisation of T lymphocytes from sural nerve biopsies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Ben-Smith A, Gaston JS, Barber PC, Winer JB.
    J Neurol Neurosurg Psychiatry; 1996 Oct 17; 61(4):362-8. PubMed ID: 8890774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.